The Physician-First Strategy Driving Skincare Growth

Podcast
August 20, 2026
Share:

What does it take to scale a science-backed skincare brand while staying focused on the physicians, practices, and clinical research behind its growth?

In this episode of Skytale Insights, host Annie Robertson Hockey talks with Zubin Meshginpoosh, President & CEO of Senté, about the strategy behind growing a science-driven skincare brand and the rise of regenerative skincare in aesthetics.

Drawing on his experience in private equity, aesthetics, and skincare, Zubin shares why operational focus has been critical to Senté’s growth and why the physician channel remains a cornerstone of the brand’s strategy. He explains how Senté approaches e-commerce as a complement to its professional partners, protects brand and price integrity across channels, and helps practices make skincare a meaningful, recurring part of the patient relationship.

Annie and Zubin also explore how regenerative skincare is changing the conversation around skin health. From longevity and cellular health to the growing overlap between aesthetics and wellness, they discuss why consumers are looking beyond visible results to better understand the science and biology behind healthier skin.

In this episode, they discuss:

  • Why the physician channel remains central to Senté’s growth strategy
  • How private equity experience shaped Zubin’s approach to operational focus and disciplined growth
  • How skincare brands can approach DTC and e-commerce without competing with their professional partners
  • The role of skincare as a recurring revenue stream for med spas and aesthetic practices
  • Why patient retention and repeat purchases matter more than the first sale
  • How Senté approaches product innovation while staying focused on its core brand
  • The rise of regenerative skincare, longevity, and “skin span”
  • Why aesthetics and wellness are becoming increasingly connected
  • The shift from results-led skincare marketing toward greater emphasis on ingredients, biological pathways, and science
  • What Zubin believes success could look like for Senté over the next five years

 

Every business deserves an ally